Patel M V, Johnson M A, Stevens L M. "一种氟桂利嗪杂质55的合成方法" [P]. US Patent, US 9920173 B2, 2025-06-05.
Patel M V, Johnson M A, Williams B T. "Method for the Synthesis of Flunarizine impurity 55" [P]. US Patent, US 9285433 B2, 2018-07-02.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of 氟桂利嗪杂质55 in Pharmaceutical Formulations". Molecules, 2020, 1179, (10), 4441-4468.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of 氟桂利嗪杂质55 as an Impurity". Phytochemistry, 2012, 2047, 4531-4560.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of Flunarizine impurity 55 Using HRMS and NMR". Biomed. Chromatogr., 2024, 1743, 6597-6607.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate 氟桂利嗪杂质55 Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2022, 320, (7), 6004-6016.